medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2013, Number 2

<< Back Next >>

Rev Esp Med Quir 2013; 18 (2)

Myofascial Pain Syndrome. Epidemiology, Pathophysiology, Diagnosis and Treatment

Villaseñor MJC, Escobar RVH, de la Lanza ALP, Guizar RBI

Language: Spanish
References: 90
Page: 148-157
PDF size: 371.16 Kb.


ABSTRACT

The myofascial pain syndrome is defined by the presence of myofascial trigger points in a palpable taut band that produces pain and tenderness in the muscle or its fascia. It is a common cause of musculoskeletal pain that is associated, in the majority of cases, with other pathologies and increases the comorbidities of these primary entities. Understanding the pathophysiology and the pharmacological and non-pharmacological treatments provides better tools to the clinician in order to improve the quality of life of the patients who suffers pain. In Mexico it is an underdiagnosed disease despite has a high prevalence. This paper reviews the epidemiology, pathophysiology, diagnosis and treatment of myofascial pain syndrome.


REFERENCES

  1. Calcina-Berna A, Moreno Millán N, González-Barboteo J, Solsona Díaz L. Porta Sales J. Frequency of pain as a reason for visiting a primary care clinic and its influence on sleep. Atención Primaria 2011;43:568-575.

  2. International Association for the Study of Pain. IASP Taxonomy. Disponible en:

  3. Bennett R. Myofascial pain syndromes and their evaluation. Best Practice & Research in Clinical Rheumatology 2007;3:427-445.

  4. Simons DG, Treavell JG, Simons LS. Myofascial pain and dysfunction: the trigger point manual. Baltimore: Williams & Wilkins, 1999.

  5. Simons DG. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyography Kinesiology 2004;14:95-107.

  6. Alvarez-Nemegyei JA, Peláez-Ballestas I, Sanin LH, Cardiel MH, et al. Prevalence of musculoskeletal pain and rheumatic diseases in the Southeastern region of Mexico. A COPCORD-based community survey. J Rheumatol 2011;86:21-25.

  7. Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2011;25:173-183.

  8. Staud R. Future perspectives: pathogenesis of chronic muscle pain. Best Pract Res Clin Rheumatol 2007;21:581-596.

  9. Simons DG. Clinical and etiological update of myofascial pain from trigger points. J Musculoskelet Pain 1996;4:93-122.

  10. Martín-Herrero C, Rodrigues de Souza DP, Alburquerque- Sendín F, Ortega-Santiago R, Fernández-de-Las-Peñas C. Myofascial trigger points, pain, disability and quality of sleep in patients with chronic tension-type headache: a pilot study. Revista de Neurología 2012;55:193-199.

  11. Giamberardino MA, Tafuri E, Savini A, Fabrizio A, et al. Contribution of myofascial trigger points to migraine symptoms. J Pain 2007;8:869-878.

  12. Fernández-Pérez AM, Villaverde-Gutiérrez C, Mora-Sánchez A, Alonso-Blanco C, et al. Muscle trigger points, pressure pain threshold, and cervical range of motion in patients with high level of disability related to acute whiplash injury. J Orthop Sports Phys Ther 2012;42:634- 641.

  13. Sari H, Akarirmak U, Uludag M. Active myofascial trigger points might be more frequent in patients with cervical radiculopathy. Eur J Phys Rehab Med 2012;48:237-244.

  14. Seo HG BM, Chung SG, Jung SH, Lee SU. Effect of electrical stimulation on botulinum toxin A therapy. Arch Phys Med Rehabil 2012;62:600-610.

  15. Malanga G, Wolff E. Evidence-informed management of chronic low back pain with trigger point injections. Spine J 2008;8:243-252.

  16. Kim DS, Jeong TY, Kim YK, Chang WH, et al. Usefulness of a myofascial trigger point injection for groin pain in patients with chronic prostatitis/chronic pelvic pain syndrome: a pilot study. Arch Phys Med Rehabil 2013;94:930-936.

  17. Fernández-de-Las-Peñas C, Galán-del-Río F, Alonso-Blanco C, Jiménez-García R, et al. Referred pain from muscle trigger points in the masticatory and neck-shoulder musculature in women with temporomandibular disoders. J Pain 2010;11:1295-1304.

  18. Gerwin R. Myofascial pain syndrome: here we are, where must we go. J Musculoskelet Pain 2010;18:329-347.

  19. Simons D, Hong C, Simons L. Endplate potentials are common to midfiber myofacial trigger points. Am J Phys Med Rehabil 2002;81:212-222.

  20. Kuan T, Hsieh Y, Chen S, Chen J, et al. The myofascial trigger point region: correlation between the degree of irritability and the prevalence of endplate noise. Am J Phys Med Rehabil 2007;86:183-189.

  21. Couppé C, Midttun A, Hilden J, Jorgensen U, Oxholm P, Fuglsang-Frederiksen A. Spontaneous needle electromyographic activity in myofascial trigger points in the infraespinatus muscle: a blinded assesment. J Musculoskelet Pain 2001;9:7-17.

  22. Chung J, Ohrbach R, McCall WJ. Characteristics of electrical activity in trapezius muscles with myofascial pain. Clin Neurophysiol 2006;117:2459-2466.

  23. Liley A. An investigation of spontaneous activity at the neuromuscular junction of the rat. J Physiol 1956;132:650-666.

  24. Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine 1993;18:1803-1807.

  25. Kuan TS CJ, Chen SM, Chien CH, Hong CZ. Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 2002;81:521-523.

  26. Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodywork Movement Ther 2007;12:371-384.

  27. McPartland J. Travell trigger points-molecular and osteopathic perspectives. J Am Osteopathic Assoc 2004;104:244-249.

  28. Gerwin RD. The taut band and other mysteries of the trigger point: an examination of the mechanisms relevant to the development and maintenance of the trigger point. J Musculoskelet Pain 2008;16:115-121.

  29. Simons D, Stolov W. Microscopic features and transient contraction of palpable bands in canine muscle. A J Phys Med 1976;55:65-88.

  30. Kuan TS, Chen JT, Chien H, Hong CZ, et al. The spinal cord connections of the myofascial trigger spots. Eur J Pain 2007;6:624-634.

  31. Shah JP, Danoff JV, Desai MJ, Parikh S, et al. Biochemicals associated with pain and inflammation are elevated in sites near to, and remote from active myofascial trigger points. Arch Phys Med Rehab 2008;89:16-23.

  32. Hong CZ. Myofascial pain therapy. J Musculoskel Pain 2004;12:37-43.

  33. Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep 2006;10:345-349.

  34. Kao MJ, Han TI, Kuan TS, Hsieh YL, et al. Myofascial trigger points in early life. Arch Phys Med Rehabil 2007;88:251-254.

  35. Hong CZ. Algometry in evaluation of trigger points and referred pain. J Musculoskel Pain 1998;6:47-59.

  36. Xu YM, Ge HY, Arendt-Nielsen L. Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain 2010;11:1348-1355.

  37. Hong CZ, Torigoe Y. Electrophysiologic characteristics of localized twitch responses in responsive bands of rabbit skeletal muscle fibers. J Musculoskelet Pain 1994;2:17-43.

  38. Hong CZ, Torigoe Y, Yu J. The localized twitch responses in responsive bands of rabbit skeletal muscle fibers are related to the reflexes at spinal cord level. J Musculoskelet Pain 1995;3:15-33.

  39. Hoheisel U, Mense S, Simons DG, Yu XM. Appearence of new receptive fields in rat dorsal horn neurons following noxius stimulation of skeletal muscle: a model for referral of muscle pain? Neuroscience Letter 1993;153:9-12.

  40. Vecchiet L, Vecchiet J, Giamberdino MA. Referred muscle pain: clinical and pathophysiologic aspects. Current Review Pain 1999;3:489-498.

  41. Mense S, Simons DG. Muscle pain: understanding its nature, diagnosis, and treatment. Philadelphia: Lippincott Williams & Wilkins, 2001.

  42. Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanism of myofascial trigger points. Arch Phys Med Rehab 1998;79:863-872.

  43. Tough EA, White AR, Richards S, Campbell J. Variability of criteria used to diagnose myofascial trigger point pain syndrome. Evidence from a review of the literature. Clin J Pain 2007;23:278-286.

  44. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.

  45. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600-610.

  46. Sikdar S, Shah JP, Gebreab T, Yen RH, et al. Novel applications of ultrasound technology to visualize and characterize myofascial trigger points and surrounding soft tissue. Arch Phys Med Rehabil 2009;90:829-838.

  47. Niraj G, Collet BJ, Bone M. Ultrasound-guided trigger point injection: first description of changes visible on ultrasound scanning in the muscle containing the trigger point. Br J Anaesth 2011;107:474-475.

  48. Rha DW, Shin JC, Kim YK, Jung JH, et al. Detecting local twitch responses of myofascial trigger points in the lowerback muscles using ultrasonography. Arch Phys Med Rehabil 2011;90:1576-1580.

  49. Lewis J, Tehan P. A blinded pilot study investigating the use of diagnostic ultrasound for detecting active myofascial trigger points. Pain 1999;79:39-44.

  50. Ballyns JJ, Shah JP, Hammond J, Gebreab T, et al. Objective sonographic measures for characterizing myofascial trigger points associated with cervical pain. J Ultrasound Med 2011;30:1331-1340.

  51. Chen Q, Bensamoun S, Basford JR, Thompson JM, An KN. Identification and quantification of myofascial taut bands with magnetic resonance elastography. Arch Phys Med Rehab 2007;88:1658-1661.

  52. Wong CK. Strain counterstrain: current concepts and clinical evidence. Man Ther 2012;17:2-8.

  53. Han SC, Harrison P. Myofascial pain syndrome and triggerpoint management. Reg Anesth 1997;22:89-101.

  54. Hains G, Descarreaux M, Hains F. Chronic shoulder pain of myofascial origin: a randomized clinical trial using ischemic compression therapy. J Manipulative Physiol Ther 2010;33:362-369.

  55. Electrotherapy Standars Committee. Electrotherapeutic terminology in physical therapy (report). Alexandria VA: 2001.

  56. Gul K, Onal SA. Comparison of non-invasive techniques in treatment of patients with myofascial pain syndrome. Agri 2009;21:104-12.

  57. Chu J. Early observations in radiculopathic pain control using electrodiagnostically derived new treatment techniques: automated twitch-obtaning intramuscular stimulation (ATOIMS) and electrical twitch-obtaning intramuscular stimulation (ETOIMS). Electromyography Clin Neurophysiol 2000;40:195-204.

  58. Chu J. Twitch-obtaining intramuscular stimulation (TOIMS): long term observations in the management of chronic partial cervical radiculopathy. Electromyography Clin Neurophysiol 2000;40:503-510.

  59. Chu J, Schwartz I. ETOIMS twitch relief method in chronic refractory myofascial pain (CRMP). Electromyography Clin Neurophysiol 2008;48:311-320.

  60. Kaya A, Kamanli A, Ardicoglu O, Ozgocmen S, et al. Direct current therapy with/without lidocaine iontophoresis in myofascial pain syndrome. Bratisl Lek Listy 2009;110:185-181.

  61. Brosseau L, Welch V, Wells G, et al. Low level laser therapy (classes I, II and III) for the treatment of osteoarthritis. Cochrane Database Syst Rev 2000;2:CD002046.

  62. Honmura A, Ishii A, Yanase M, Obata J, Haruki E. Analgesic effect of Ga-Al-As diode laser irradiation on hyperalgesia in carrageenin-induced inflammation. Lasers Surg Med 1993;13:463-469.

  63. Lee G, Wong E, Mason DT. New concepts in pain management and in the application of low-power laser for relief of cervicothoracic pain syndromes. Am Heart J 1996;132:1329- 1334.

  64. Gur A, Sarac AJ, Cevik R, Altindag O, Sarac S. Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: a double-blind and randomize-controlled trial. Lasers Surg Med 2004;35:229-235.

  65. Hakguder A, Birtane M, Gürcan S, Kokino S, Turan FN. Efficacy of low level laser therapy in myofascial pain syndrome: an algometric and thermographic evaluation. Lasers Surg Med 2003;33:339-343.

  66. Shirani AM, Gutknecht N, Taghizadeh M, Mir M. Low-level laser therapy and myofacial pain dysfunction syndrome: a randomized controlled clinical trial. Lasers Med Sci 2009;24:715-720.

  67. Aguilera FJ, Martín DP, Masanet RA, Botella AC, Soler LB, Morell FB. Immediate effect of ultrasound and ischemic compression techniques for the treatment of trapezius latent myofascial trigger points in healthy subjects: a randomized controlled study. J Manipulative Physiol Ther 2009;32:515- 520.

  68. Ay S, Dogan SK, Evcik D, Baser OC. Comparison of the efficacy of phonophoresis and ultrasound therapy in myofascial pain syndrome. Rheumatol Int 2011;31:1203-1208.

  69. Majlesi J, Unalan H. High-power pain threshold ultrasound technique in the treatment of active myofascial trigger points: a randomized, double-blind, case-control study. Arch Phys Med Rehabil 2004;85:833-836.

  70. Srbely JZ, Dickey JP. Randomized controlled study of the antinociceptive effect of ultrasound on trigger point sensitivity: novel applications in myofascial therapy? Clin Rehabil 2007;21:411-417.

  71. Srbely JZ, Dickey JP, Lowerison M, Edwards AM, et al. Stimulation of myofascial trigger points with ultrasound induces segmental antinociceptive effects: a randomized controlled study. Pain 2008;139:260-266.

  72. Vane JR. The fight against rheumatism: from willow bark to COX-1 sparing drugs. J Physiol Pharmacol 2000;51:573-586.

  73. Manfredini D, Landi N, Tognini F, Orlando B, Bosco M. Muscle relaxants in the treatment of myofascial face pain. A literature review. Minerva Stomatol 2004;53:305-313.

  74. Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain 1997;11:139-146.

  75. Di Rienzo Businco L, Di Rienzo Businco A, D’Emilia M, Lauriello M, Coen Tirelli G. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Acta Otorhinolaryngol Ital 2004;24:279-283.

  76. Affaitati G, Fabrizio A, Savini A, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther 2009;31:705-720.

  77. Hsieh L, Hong CZ, Chern SH, Chen CC. Efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of the upper trapezius. J Pain Symptom Manage 2010;39:116-125.

  78. Malanga G, Reiter RD, Garay E. Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother 2008;9:2209-2215.

  79. Berry H, Hutchinson DR. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res 1988;16:75-82.

  80. Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J Int Med Res 1988;16:83-91.

  81. Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomandibular Disord 1991;5:179-186.

  82. Fishbain D, Cutler R, Rosomoff H, Rosomoff R. Clonazepam open clinical treatment trial for myofascial syndrome associated chronic pain. Pain Med 2000;1:332-339.

  83. Simons DG, Travell JG, Simons LS. Myofascial pain and dysfunction:the trigger point manual. In: Upper half of body (vol. 1). Baltimore: Williams & Wilkins, 1999.

  84. Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med 1994;73:256-263.

  85. Cummings TM. White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehab 2001;82:986-992.

  86. Tekin L, Akarsu S, Durmus O, Cakar E, et al. The effect of dry needling in the treatment of myofascial pain syndrome: a randomized double-blinded placebo-controlled trial. Clin Rheumat 2013;32:309-315.

  87. Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, et al. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005;25:604-611.

  88. Graboski CL, Gray DS, Burnham RS. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain 2005;118:170-175.

  89. Ay S, Evcik D, Tur BS. Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol 2010;29:19-23.

  90. Müller-Schwefe G, Uberall MA. Dysport® for the treatment of myofascial back pain: results from an open-label, phase II, randomized, multicenter, dose-ranging study. Scand J Pain 2011;2:25-33.




2020     |     www.medigraphic.com